Respiratory Syncytial Virus

The Pharmacy Times® Respiratory Syncytial Virus Resource Center is a comprehensive source for clinical news and expert insights on treating and preventing respiratory syncytial virus.

Latest News

Blood collection tubes Respiratory syncytial virus(RSV) test positive results,medical concept - Image credit: JUN LI | stock.adobe.com
RSV Vaccination Could Decrease Hospitalization Among Adults 60 Years and Older

September 6th 2024

RSV vaccination was 75% effective in preventing RSV-associated hospitalizations among adults aged 60 years and older.

New ACIP Recommendations for RSV Vaccines Aim to Solve Challenges With Shared Clinical Decision-Making
New ACIP Recommendations for RSV Vaccines Aim to Solve Challenges With Shared Clinical Decision-Making

August 30th 2024

Infectious viruses such as respiratory syncytial virus (RSV) causing respiratory infections - Image credit: Artur | stock.adobe.com
Study: Researchers Find New Drug Target to Treat RSV

August 29th 2024

Vaccine bottles and syringes for preventing respiratory syncytial virus (RSV) - Image credit: kitsawet | stock.adobe.com
Single Dose of Abrysvo Could Provide Immune Protection Against RSV in Immunocompromised Individuals

August 22nd 2024

Vaccine booster concept faded background - vials of generic vaccines with syringe and stethoscope - Image credit: MargJohnsonVA | stock.adobe.com
Study: How mRNA-1345 RSV Vaccine Compares to Previously Approved RSV Vaccines

August 5th 2024

Latest CME Events & Activities

Influenza Prevention in the At-Risk Adult Population and the Pharmacist's Role in an Evolving Influenza Vaccin...

1.25 Credits / Immunization, Infectious Diseases

View More

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Ac...

1.5 Credits / HIV/AIDS, Infectious Diseases

View More

Pneumococcal Disease Prevention for Older Adults and the Pharmacist’s Role in an Evolving Vaccine Landscape

1.0 Credit / Immunization, Infectious Diseases

View More

More News

Ibuprofen Demonstrates Immune Benefits Against Respiratory Syncytial Virus

Ibuprofen Demonstrates Immune Benefits Against Respiratory Syncytial Virus

Skylar Kenney, Assistant Editor
November 22nd 2021

RSV causes an estimated 14,000 deaths and 177,000 hospitalizations annually among US adults over 65 years of age.

Read More

Masking, Social Distancing During COVID-19 Pandemic Stopped Flu, RSV Spread During 2020 Cold and Flu Season

Masking, Social Distancing During COVID-19 Pandemic Stopped Flu, RSV Spread During 2020 Cold and Flu Season

Jill Murphy, Associate Editor
October 11th 2021

The study aimed to examine the impact of masking and social distancing practices used to control the spread of COVID-19.

Read More

FDA Grants Emergency Use Authorization for Single Test to Differentiate Between COVID-19, Flu, RSV

FDA Grants Emergency Use Authorization for Single Test to Differentiate Between COVID-19, Flu, RSV

Skylar Kenney, Assistant Editor
October 8th 2021

Samples for the test are isolated from nasopharyngeal swabs, anterior nasal swabs, and mid-turbinate swabs.

Read More

Pfizer To Start Phase 3 Clinical Trial in Adults for Investigational Respiratory Synctial Virus Vaccine

Pfizer To Start Phase 3 Clinical Trial in Adults for Investigational Respiratory Synctial Virus Vaccine

Jill Murphy, Associate Editor
September 7th 2021

RSV is defined as a seasonal illness that starts in the fall months and peaks during the winter when other respiratory illnesses are more common.

Read More

Respiratory Syncytial Virus Testing Not Common Among Pregnant Women

Respiratory Syncytial Virus Testing Not Common Among Pregnant Women

Brandon May
June 22nd 2018

Testing for respiratory syncytial virus (RSV) infection during the influenza season is uncommon among pregnant mothers.

Read More

<123456